Recombinant ODC1 anticorps (full length)
Aperçu rapide pour Recombinant ODC1 anticorps (full length) (ABIN7878764)
Antigène
Voir toutes ODC1 AnticorpsType d'anticorp
Reactivité
Hôte
Clonalité
Conjugué
Application
Classe de qualité
Clone
-
-
Épitope
- full length
-
Fonction
- Recombinant Ornithine Decarboxylase Antibody / ODC1 (azide and preservative free)
-
Purification
- Protein A/G affinity
-
Immunogène
- Recombinant full-length human protein was used as the immunogen for the recombinant Ornithine Decarboxylase antibody.
-
Isotype
- IgG1, kappa
-
-
-
-
Indications d'application
- Optimal dilution of the recombinant Ornithine Decarboxylase antibody should be determined by the researcher.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 mg/mL
-
Buffer
- 1 mg/mL in 1X PBS, BSA free, sodium azide free
-
Agent conservateur
- Azide free
-
Stock
- -20 °C
-
Stockage commentaire
- Aliquot the recombinant Ornithine Decarboxylase antibody and store frozen at -20oC or colder. Avoid repeated freeze-thaw cycles.
-
-
- ODC1 (Ornithine Decarboxylase 1 (ODC1))
-
Autre désignation
- Ornithine Decarboxylase
-
Sujet
- Recognizes a 51-53 kDa protein, identified as the Ornithine Decarboxylase (ODC-1). ODC is the initial and rate-limiting enzyme in the biosynthetic pathway of polyamines and is involved in the conversion of ornithine to putrescine. The biological activity of ODC-1 is rapidly induced in response to virtually all agents known to promote cell proliferation including hormones, drugs, growth factors, mitogens, and tumor promoters. Reportedly, ODC mRNA levels are elevated in lung carcinomas as well as in colon adenomas and carcinomas. ODC activity in colorectal carcinomas is greater than those in adenomas and normal mucosa.
-
UniProt
- P11926
Antigène
-